NirsevimabMeSH Supplementary Concept

https://ansm.sante.fr/actualites/prevention-de-la-bronchiolite-du-nourrisson-les-premieres-donnees-de-pharmacovigilance-confirment-le-profil-de-securite-du-nirsevimab-beyfortus
2024
false
false
false
France
French
bronchiolitis, viral
infant, newborn
infant
pharmacovigilance
respiratory syncytial virus infections
nirsevimab
nirsevimab
risks and benefits
Benefit-Risk assessment
hospitalization
investigative report
drug information
technical report
nirsevimab

---
https://www.cbip.be/fr/articles/4383?folia=4379
2024
false
false
false
Belgium
French
journal article
drug information
infant
respiratory syncytial virus infections
hospitalization
nirsevimab
nirsevimab

---
https://www.sfpediatrie.com/sites/www.sfpediatrie.com/files/medias/documents/Communiqu%C3%A9_SFP_20112024_VF.pdf
2024
France
scientific and technical information
bronchiolitis
alarm, nos
nirsevimab
child, nos
respiratory syncytial viruses
bronchiolitis, nos
family
Pediatricians
child
pediatrics
residence characteristics
nirsevimab
pediatrician
family, nos
community

---
https://www.has-sante.fr/jcms/p_3556743/fr/beyfortus-nirsevimab-virus-respiratoire-syncytial
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
infant, newborn
infant
bronchiolitis, viral
acute disease
Acute bronchiolitis caused by respiratory syncytial virus (disorder)
nirsevimab
evaluation of the transparency committee
respiratory syncytial virus infections
nirsevimab

---
https://sante.gouv.fr/IMG/pdf/dgs-urgent_-19_mise_a_disposition_beyfortus.pdf
2023
France
scientific and technical information
Nirsevimab
nirsevimab
Deimmunization
nirsevimab
vaccination, nos
Temporary
patients
Immunization
transitory
has patient
immunization
Patient

---
https://www.cnge.fr/conseil_scientifique/productions_du_conseil_scientifique/nirsevimab_beyfortus_en_prevention_des_infections_/
2023
France
scientific and technical information
Verbal Rating Scale
Vienna Rectoscopy Score
Respiratory System Finding
Preventive Intervention
Respiratory System
respiratory tract infections
infection control
Nirsevimab
Prevention Study
nirsevimab
infectious disease, nos
Prevention
respiratory syncytial virus infections
Chuvash Language
Infection
nirsevimab

---
https://www.cmg.fr/wp-content/uploads/2023/10/Fiche-Nirsevimab-actualisee-20230928.pdf
2023
France
scientific and technical information
monoclonal antibody
respiratory syncytial viruses
Chuvash Language
bronchiolitis
nirsevimab
infant
nirsevimab
bronchiolitis, nos
Verbal Rating Scale
Vienna Rectoscopy Score
Prevention
Bronchiolitis
antibodies, monoclonal
Nirsevimab
Prevention Study
blood group antibody vr
Use
Preventive Intervention

---
https://www.has-sante.fr/jcms/p_3461236/fr/nirsevimab-beyfortus-dans-la-prevention-des-bronchiolites-a-virus-respiratoire-syncytial-vrs-chez-les-nouveau-nes-et-les-nourrissons
2023
false
false
false
France
nirsevimab
bronchiolitis, viral
respiratory syncytial virus infections
infant, newborn
antibodies, monoclonal, humanized
injections, intramuscular
guidelines for drug use
infant
nirsevimab

---
https://www.cmg.fr/prevention-des-bronchiolites-a-vrs-des-nourrissons-par-lutilisation-dun-anticorps-monoclonal-au-cabinet-le-nirsevimab-beyfortus/
2023
false
false
false
France
scientific and technical information
antibodies, monoclonal
blood group antibody vr
bronchiolitis, nos
infant
Monoclonal antibodies
Monoclonal antibodies
bronchiolitis
nirsevimab
respiratory syncytial viruses
monoclonal antibody
Bronchiolitis
nirsevimab

---
https://sante.gouv.fr/IMG/pdf/dgs-urgent_2023_12_beyfortus.pdf
2023
France
scientific and technical information
nirsevimab
judgment
prescription, nos
bronchiolitis
respiratory syncytial viruses
bronchiolitis, nos
nirsevimab
Bronchiolitis
aptitude

---
https://www.has-sante.fr/jcms/p_3456503/fr/beyfortus-nirsevimab-virus-respiratoire-syncytial
2023
false
false
false
France
nirsevimab
treatment outcome
insurance, health, reimbursement
infant, newborn
infant
respiratory syncytial virus infections
injections, intramuscular
evaluation of the transparency committee
nirsevimab

---
https://sante.gouv.fr/IMG/pdf/dgs-urgent_no2023-20_-_suspension_des_prescriptions_en_100mg.pdf
2023
France
scientific and technical information
nirsevimab
transitory
Suspension Dosage Form Category
Suspension
nirsevimab
Nirsevimab
Suspension
suspension, nos
Temporary
delivery, obstetric
Dispense
suspensions

---
https://www.ema.europa.eu/en/medicines/human/EPAR/beyfortus
2022
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
nirsevimab
nirsevimab
nirsevimab
drug approval
europe
infant, newborn
infant
child
critical illness
respiratory syncytial virus infections
injections, intramuscular
drug interactions
F protein, human respiratory syncytial virus

---